Latest news and articles about obesity treatment from NEX English
Eli Lilly has announced that its new drug 'Foundio' has received approval from the US Food and Drug Administration, paving the way for strong competition in the oral obesity medication market. This development comes as companies strive to provide effective solutions to the global obesity crisis.
The UAE's health authority has approved a new oral treatment for obesity, set to be available to the public starting May 2024. This initiative is part of the country's efforts to combat obesity and improve the health of its citizens and residents.
The UAE has announced the approval of a new weight loss medication that is taken daily in pill form, eliminating the need for injections. This development marks a significant step in addressing obesity in the region.
The U.S. Food and Drug Administration (FDA) has approved the weight loss drug "Fondue," developed by Eli Lilly. This decision comes at a time when effective solutions to combat obesity, a global health crisis, are increasingly needed.
A team of scientists has uncovered a key protein's role in activating brown fat, which is crucial for burning energy instead of storing it. This discovery could pave the way for new treatments to combat obesity, a growing global health challenge.